Which Insiders Are Buying GeoVax Labs Inc. (GOVX) Shares?

The stock of GeoVax Labs Inc. (NASDAQ:GOVX) increased by $0.02 on Wednesday to $0.60, up 3.46 percent. The last five days have seen an average of 318,764 shares of common stock traded. 5 times new highs were reached in the current year, with a fall of -$0.0230. The average number of shares traded over the last 20 days was 345,696, while the average volume over the last 50 days totaled 390,196.

GOVX stock appreciated 7.70% since last month. On 08/21/23, the company’s shares reached a one-month low of $0.5100. The stock touched a high of $1.85 on 01/25/23, after rallying from a low of $0.51 in 52 weeks. The price of GOVX stock has declined by -4.28% or -$0.0230 this year, reaching a new high 5 times. Still, the stock price is down -67.39% from the 52-week high.

Insider Transactions

GOVX stock investors should be aware that GeoVax Labs Inc. (GOVX) stock had its last reported insider trading activity 5 days ago on Aug 25. On Aug 25, President, CEO DODD DAVID A acquired 35,087 shares at $0.57 each. This transaction resulted in the insider spending $20,000. On Aug 18, Reynolds Mark added 10,000 shares at a price of US$0.52. After the transaction, the insider now owns 78,184 shares. President, CEO DODD DAVID A had earlier bought 32,000 shares on Apr 24 for $0.64 a share. The transaction was completed for $20,445.

Financial Health

For the three months ended June 29, GeoVax Labs Inc.’s quick ratio was 5.70, while its current ratio was 5.70, indicating its ability to pay off its debt. Based on annual data, it had gross profit of $14.11 million and revenue of $82000.0.

Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. GOVX’s return on assets (ROA) during the last 12 months has been -43.00%. In the meantime, the return on equity (ROE) for the last 12 months was -51.40%.

Earnings Surprise

According to GeoVax Labs Inc.’s quarterly financial report for the quarter that ended June 29. It was predicted that GeoVax Labs Inc.’s quarterly earnings would be -$0.22, but it ended up being -$0.16, beating the consensus by -37.50%. Equity owned by shareholders amounts to $26.44 million.

Technical Picture

Here’s a quick look at GeoVax Labs Inc.’s (GOVX) price momentum from a technical perspective. As of 29 August, the RSI 9-day stood at 63.14%, suggesting the stock is Neutral, with a 66.25% historical volatility rate.

The stochastic %K and %D were 57.19% and 49.46% respectively, while the average true range (ATR) was 0.0399. Based on the 14-day stochastic reading of 69.43%, the RSI (14) reading is 59.02%. On the 9-day MACD Oscillator, the stock is at 0.0169, and the 14-day reading is at 0.0316.

Analyst Ratings

In its analyst report released on November 19, 2020, Maxim Group began covering GeoVax Labs Inc. (NASDAQ: GOVX). The stock was rated as a Buy by the brokerage firm. Analysts have assigned GeoVax Labs Inc. (GOVX) an Buy rating. GOVX is a stock that is recommended for selling by 0 brokerage firms, while 0 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 3 others recommend it as a buy.

What is GOVX’s price target for the next 12 months?

The current consensus forecast for the stock is between $4.00 and $6.00, with a median target price of $6.00. In analyzing these forecasts, the average price target given by analysts for GeoVax Labs Inc. (GOVX) is $5.33.

Most Popular

Related Posts